Agreed....it is all about revenue increases and new contracts. If Halozyme gets their approval in the next few months, we could get a very quick ramp up and increase in projections....after our recent run up, it will not take a lot of news to push us to double figures.
Conversely, if the major contract or contracts are delayed, this could very well trend down somewhat lower....hopefully not!
Remember that while it feels good when we go higher every day, generally stocks do need to take a breather and consolidate, and yes sometimes we go from overbought to grossly oversold until we stabilize, but this is not the PPHM of old....this group has a solid business plan on very achievable objectives in a marketplace of high demand....their execution has been spot on, we just have to wait for FDA approvals and the contracts will come.
News 
Market Data 
Discover 
